The Mississippi Center for Clinical and Translational Research is an ambitious enterprise designed to promote the success of research focusing on all major diseases that impact Mississippians at our five CCTR partner institutions - the University of Mississippi Medical Center, the University of Mississippi, Mississippi State University, Tougaloo College and the University of Southern Mississippi. Our mission is to develop a powerful and sustainable research enterprise that will have an important public health impact by reducing obesity and cardiometabolic-related diseases in Mississippi.
The center is funded by an Institutional Development Award Program Infrastructure for Clinical and Translational Research grant through the National Institute of General Medicine Sciences. This $19.8 million grant seeks to improve the health of Mississippians by providing the infrastructure needed to support research projects across this multi-institutional venture.
The University of Mississippi Medical Center had a record year for research and sponsored programs funding, receiving $123.5 million from 392 separate grants, awards and contracts during fiscal year 2021.
For years, clinical trials have tried and failed to discover an effective treatment for a common kind of heart failure.
That is, until a global study co-led by a University of Mississippi Medical Center physician found convincing evidence for a new approach to treat heart failure with preserved ejection fraction, or HFpEF.
Get news and information you need about the Mississippi Center for Clinical and Translational Research by connecting with us through our social media community. The center is active on Twitter, Facebook, Instagram and LinkedIn.
We look forward to hearing from you!